Latest Articles

Publication Date
Approval From European Commission With Two New Indications in Gynecologic Cancers - businesswire.com

Approval From European Commission With Two New Indications in Gynecologic Cancers businesswire.com

Published: Oct. 24, 2024, 10:45 a.m.
‘Small Increase’ in Breast Cancer With Levonorgestrel IUD? - Medscape

‘Small Increase’ in Breast Cancer With Levonorgestrel IUD? Medscape

Published: Oct. 24, 2024, 9:51 a.m.
FACT SHEET: Biden-Harris Administration Announces $110 Million in Awards from ARPA-H's Sprint for Women's Health to Accelerate New Discoveries and Innovation - The American Presidency Project

FACT SHEET: Biden-Harris Administration Announces $110 Million in Awards from ARPA-H's Sprint for Women's Health to Accelerate New Discoveries and Innovation The American Presidency Project

Published: Oct. 24, 2024, 7:05 a.m.
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - BioSpace

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation BioSpace

Published: Oct. 24, 2024, 5:36 a.m.
MPs push Treasury to allocate funds for referral hospitals for waived bills - The Standard

MPs push Treasury to allocate funds for referral hospitals for waived bills The Standard

Published: Oct. 24, 2024, 4:48 a.m.
Jeon Bo-ram Reveals Shocking News After Leaving T-ARA: “Uterine Cyst Found” - KBIZoom

Jeon Bo-ram Reveals Shocking News After Leaving T-ARA: “Uterine Cyst Found” KBIZoom

Published: Oct. 24, 2024, 2:45 a.m.
Casio to Release MR-G Inspired by the Brilliant Gleam of Japanese Katana Swords - bastillepost.com

Casio to Release MR-G Inspired by the Brilliant Gleam of Japanese Katana Swords bastillepost.com

Published: Oct. 24, 2024, 1 a.m.
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - PR Newswire

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation PR Newswire

Published: Oct. 24, 2024, 12:08 a.m.
Professor Eva Dimitriadis leads breakthrough discovery into cause of unexplained infertility - Neos Kosmos

Professor Eva Dimitriadis leads breakthrough discovery into cause of unexplained infertility Neos Kosmos

Published: Oct. 23, 2024, 11 p.m.
There's still a lot we don't know about ovarian cancer, says Colorado doctor - MSN

There's still a lot we don't know about ovarian cancer, says Colorado doctor MSN

Published: Oct. 23, 2024, 10:29 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!